Crititech Overview
- Founded
- 1997

- Status
- Private
- Employees
- 6

- Latest Deal Type
- Debt - PPP
- Investors
- 8
Crititech General Information
Description
Manufacturer of fine-particle compounds designed to micronize a wide variety of small-molecule and biotechnology drugs. The company's fine-particle compounds utilizes its proprietary CO2 technology to develop potent molecules, poorly soluble compounds and bio-molecules with its ability to simplify formulations, enabling pharmacists to develop and manufacture unique and differentiated drugs and medical devices.
Contact Information
- 1849 East 1450 Road
- Lawrence, KS 66044
- United States
Crititech Timeline
Crititech Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Debt - PPP | 29-Apr-2020 | 000.00 | Completed | Generating Revenue | ||
7. Accelerator/Incubator | 01-Apr-2019 | 00.00 | 000.00 | Completed | Generating Revenue | |
6. Later Stage VC | 21-Aug-2014 | 00.000 | 00.000 | Completed | Generating Revenue | |
5. Debt - General | 10-Dec-2009 | 00.000 | 00.000 | Completed | Generating Revenue | |
4. Later Stage VC | 02-Dec-2008 | 00000 | 00000 | Completed | Generating Revenue | |
3. Later Stage VC | 15-Feb-2005 | 00000 | 00000 | Completed | Generating Revenue | |
2. Grant | 04-Aug-2004 | $100K | Completed | Generating Revenue | ||
1. Early Stage VC | 01-Aug-2002 | Completed | Generating Revenue |
Crititech Executive Team (10)
Crititech Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
Bala Subramaniam Ph.D | Crititech | Founder & Board Member | 000 0000 |
Matthew McClorey JD | Crititech | President & Board Member | 000 0000 |
Sam Campbell | Crititech | Chairman | 000 0000 |
William Duncan Ph.D | Self | Board Member | 000 0000 |
Crititech Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCrititech Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Accelerate Venture Partners | Angel Group | Minority | 000 0000 | 000000 0 | |
SeedStep Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
Tony Schmidt | Angel (individual) | Minority | 000 0000 | 000000 0 | |
KTECH Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Precede Fund | Venture Capital | Minority | 000 0000 | 000000 0 |
Crititech Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 (00000000 | 01-Jan-2017 | 0000 00000 | 000 | Drug Discovery | |
NanOlogy (Pharmaceutical) | 01-Jan-2015 | Joint Venture | Drug Discovery |